secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicine Man Technologies, Inc. (—)
CIK:        0001622879
Form:       8-K
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0001104659-23-066703
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Schwazze names President Nirup Krishnamurthy as CEO; founder Justin Dye becomes Chairman
--------------------------------------------------------------------------------

- Justin Dye resigned as CEO (May 24) and Executive Chairman (May 27); becomes non-executive Chairman.
- Nirup Krishnamurthy (former President) appointed CEO; $475K salary, $100K bonus, 800K options, 1.6M RSUs.
- Dye gets $300K/year Chairman compensation, $350K severance if removed before May 27, 2024 (not for cause); all stock options fully vest.
- Succession planned for nearly a year; Krishnamurthy had been President since Oct 2022; strategy continuity in CO/NM markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622879/000110465923066703/0001104659-23-066703-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622879/000110465923066703/tm2317466d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-066703

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer